• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Clinical ophthalmology >An evaluation of the accuracy of the ORange? (Gen II) by comparing it to the IOLMaster? in the prediction of postoperative refraction
【24h】

An evaluation of the accuracy of the ORange? (Gen II) by comparing it to the IOLMaster? in the prediction of postoperative refraction

机译：评估ORange的准确性？ （第二代）通过与IOLMaster进行比较？预测术后屈光

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Purpose: The aim of this study was to evaluate the accuracy of ORange? Gen II (WaveTec Vision, Aliso Viejo, CA).Setting: The Surgical Suites, Honolulu, HI.Methods: The prospective 28 consecutive cataract surgical cases were selected from 85 cataract surgical cases between December 16, 2010 and February 24, 2011. With the same intraocular lens implantation, the predicted spherical equivalent refraction from IOLMaster? (Carl Zeiss AG, Oberkochen, Germany) and ORange Gen II were statistically compared and verified with 1-month postoperative manifest refraction. The data were put into IBM SPSS 19 (SPSS Inc, Chicago, IL) for analysis of variance. Pearson's correlation coefficient was also calculated to evaluate the correlation between the IOLMaster, ORange Gen II, and 1-month postoperative manifest refraction.Results: There were no statistically significant differences in the mean spherical equivalent refraction from the IOLMaster, ORange Gen II, and 1-month postoperative manifest refraction (IOLMaster -0.40 diopters, P = 0.07; ORange Gen II -0.43 diopters, P = 0.16; 1-month refraction -0.41 diopters, P = 0.07). Pearson’s correlation study demonstrated that all three were positively correlated (P < 0.05), with the strongest correlation between the ORange Gen II and 1-month postoperative manifest refraction (r = +0.6, P < 0.01).Conclusion: The ORange Gen II can be considered as an alternative method for intraocular lens selection for cataract patients.
机译：目的：本研究的目的是评估ORange？第二代（WaveTec Vision，加利福尼亚州阿利索维耶霍）。地点：美国夏威夷州檀香山市外科套房。方法：从2010年12月16日至2011年2月24日的85例白内障手术病例中，选择了28例连续的白内障手术病例。在相同的人工晶状体植入中，IOLMaster预测的球面等效屈光度是多少？ （Carl Zeiss AG，​​Oberkochen，Germany）和ORange Gen II进行了统计学比较，并经过了术后1个​​月的明显屈光检查。将数据放入IBM SPSS 19（SPSS Inc，芝加哥，伊利诺伊州）进行方差分析。还计算了Pearson相关系数，以评估IOLMaster，ORange Gen II和术后1个月的明显屈光度之间的相关性。结果：IOLMaster，ORange Gen II和1的平均球面等效屈光度无统计学意义术后1个月屈光度（IOLMaster -0.40屈光度，P = 0.07; ORange Gen II -0.43屈光度，P = 0.16; 1个月屈光度-0.41屈光度，P = 0.07）。 Pearson的相关性研究表明，三者均呈正相关（P <0.05），ORange Gen II与术后1个月的明显屈光度之间的相关性最强（r = + 0.6，P <0.01）。被认为是白内障患者人工晶状体选择的替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号